Certain Antibiotics May Reduce the Efficacy of Certain ICIs in Cancer Patients
A new study suggests that fluoroquinolones — but not other antibiotics — may reduce the efficacy of certain ICIs in certain cancers.
A new study suggests that fluoroquinolones — but not other antibiotics — may reduce the efficacy of certain ICIs in certain cancers.
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
Researchers sought to determine CV event occurrence in patients treated with immune checkpoint inhibitors and assess the accuracy of diagnosis by ICD code compared with adjudication using established definitions.
Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
Oncology drug approvals in the United States are increasingly supported by single-arm clinical trials, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
When looking into risk factors for prostate cancer, your patients may look to lifestyle factors. While some, like diet and smoking, are seen as risks for prostate cancer development, research into alcohol has drawn multiple conclusions. What have recent studies said about alcohol and prostate cancer, and does the type of alcohol affect risk?